查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1861384

重組鱟試劑和重組C因子試劑：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Recombinant Limulus and Recombinant Factor C Reagent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 101 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年全球重組鱟和重組 C 因子試劑市場規模估計為 3,387萬美元，預計在2025-2031年預測期內將以 16.9%的年複合成長率成長，到2031年達到 1.06億美元。

本報告對近期關稅調整和國際戰略反制措施對重組鱟試劑和重組C因子試劑的跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組進行了全面評估。

重組鱟變形細胞溶解物（rCR）是一種利用基因工程技術進行的定量細菌內毒素檢測方法。此檢測方法不依賴鱟血資源，符合永續性目標。它完美模擬了天然鱟變形細胞溶解物（LAL）的酵素連結反應，包括因子 C、因子 B 和促進要素。它是唯一利用與天然鱟變形細胞溶解物（LAL）相同酶聯反應，同時消除與 1,3-BETA-D-聚葡萄糖交叉反應（可能導致假陽性結果）的內毒素檢測試劑。

重組凝血因子C（rFC）是體外重組鱟變形細胞裂解液凝血連鎖的第一步。活化的凝血因子C可直接裂解螢光基材，產生可被螢光微孔盤讀數儀偵測到的訊號。與天然鱟變形細胞裂解液（LAL）相比，重組凝血因子C法僅利用單一反應機制。

全球排名前五名的重組鱟試劑和重組C因子試劑生產商分別是Lonza、Biomerieux、Associates of Cape Cod（ACC）、FUJIFILM Wako and Xiamen Bioendo Technology，約佔市場佔有率的30%。其中，龍沙的市場佔有率領先，約40%。北美是最大的市場，約佔46%，其次是歐洲和中國，分別約佔35%和7%。依產品類型分類，重組C因子佔最大佔有率，約佔總市場佔有率的77%。依產品應用分類，醫藥用途最廣泛，其次是醫療設備用途。

本報告目的是對全球重組鱟試劑和重組C因子試劑市場依地區/國家、類型和應用進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

重組鱟試劑和重組C因子試劑的市場規模、估算和預測以銷售（千）和收入（百萬美元）為單位呈現，基準年為2024年，並包含2020年至2031年的歷史資料和預測資料。運用定量和定性分析，幫助讀者制定業務/成長策略，評估市場競爭格局，分析自身在當前市場中的地位，並就重組鱟試劑和重組C因子試劑做出明智的商業決策。

市場區隔

公司

  • Lonza
  • Biomerieux
  • Associates of Cape Cod（ACC）
  • FUJIFILM Wako
  • Xiamen Bioendo Technology
  • Rhino Bio

依類型

  • 重組鱟試劑
  • 重組因子C試劑

依應用

  • 製藥
  • 醫療設備
  • 其他

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Recombinant Limulus and Recombinant Factor C Reagent was estimated to be worth US$ 33.87 million in 2024 and is forecast to a readjusted size of US$ 106 million by 2031 with a CAGR of 16.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Recombinant Limulus and Recombinant Factor C Reagent cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Recombinant Limulus Amebocyte Lysate (rCR) is a genetically engineered quantitative bacterial endotoxin test. This test is independent of horseshoe crab blood resources, thus meeting sustainability goals. It fully mimics the enzyme-linked reaction of natural Limulus Amebocyte Lysate (LAL), including Factor C, Factor B, and procoagulant. It is the only endotoxin test reagent that utilizes the same enzyme-linked reaction as natural Limulus Amebocyte Lysate (LAL) while eliminating the cross-reaction with 1,3-B-D-glucan that can cause false-positive results.

Recombinant Factor C (rFC) is the first component of the in vitro recombinant Limulus Amebocyte Lysate coagulation cascade: Factor C. Activated Factor C directly cleaves a fluorescent substrate, generating a signal that is detected by a fluorescence microplate reader. Compared to natural Limulus Amebocyte Lysate (LAL), the recombinant Factor C method utilizes only one reaction mechanism.

Global 5 largest manufacturers of Recombinant Limulus and Recombinant Factor C Reagent are Lonza, Biomerieux, Associates of Cape Cod (ACC), FUJIFILM Wako and Xiamen Bioendo Technology, which make up about 30%. Among them, Lonza is the leader with about 40% market share. North America is the largest market, with a share about 46%, followed by Europe and China, with share about 35% and 7%. In terms of product type, recombinant factor C occupy the largest share of the total market, about 77%. And in terms of product application, the largest application is Pharmaceutical, followed by Medical Devices.

This report aims to provide a comprehensive presentation of the global market for Recombinant Limulus and Recombinant Factor C Reagent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Limulus and Recombinant Factor C Reagent by region & country, by Type, and by Application.

The Recombinant Limulus and Recombinant Factor C Reagent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Limulus and Recombinant Factor C Reagent.

Market Segmentation

By Company

  • Lonza
  • Biomerieux
  • Associates of Cape Cod (ACC)
  • FUJIFILM Wako
  • Xiamen Bioendo Technology
  • Rhino Bio

Segment by Type

  • Recombinant Limulus Reagent
  • Recombinant Factor C

Segment by Application

  • Pharmaceutical
  • Medical Devices
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Recombinant Limulus and Recombinant Factor C Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Recombinant Limulus and Recombinant Factor C Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Recombinant Limulus and Recombinant Factor C Reagent in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Recombinant Limulus and Recombinant Factor C Reagent Product Introduction
  • 1.2 Global Recombinant Limulus and Recombinant Factor C Reagent Market Size Forecast
    • 1.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value (2020-2031)
    • 1.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume (2020-2031)
    • 1.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Price (2020-2031)
  • 1.3 Recombinant Limulus and Recombinant Factor C Reagent Market Trends & Drivers
    • 1.3.1 Recombinant Limulus and Recombinant Factor C Reagent Industry Trends
    • 1.3.2 Recombinant Limulus and Recombinant Factor C Reagent Market Drivers & Opportunity
    • 1.3.3 Recombinant Limulus and Recombinant Factor C Reagent Market Challenges
    • 1.3.4 Recombinant Limulus and Recombinant Factor C Reagent Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Players Revenue Ranking (2024)
  • 2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Revenue by Company (2020-2025)
  • 2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Players Sales Volume Ranking (2024)
  • 2.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Company Players (2020-2025)
  • 2.5 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Limulus and Recombinant Factor C Reagent
  • 2.9 Recombinant Limulus and Recombinant Factor C Reagent Market Competitive Analysis
    • 2.9.1 Recombinant Limulus and Recombinant Factor C Reagent Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Limulus and Recombinant Factor C Reagent Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Limulus and Recombinant Factor C Reagent as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Recombinant Limulus Reagent
    • 3.1.2 Recombinant Factor C
  • 3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type
    • 3.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Type (2020-2031)
    • 3.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type
    • 3.3.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pharmaceutical
    • 4.1.2 Medical Devices
    • 4.1.3 Others
  • 4.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application
    • 4.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Application (2020-2031)
    • 4.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application
    • 4.3.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region
    • 5.1.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2020-2025)
    • 5.1.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2026-2031)
    • 5.1.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (%), (2020-2031)
  • 5.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region
    • 5.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2020-2025)
    • 5.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2026-2031)
    • 5.2.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.4.2 North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.5.2 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.7.2 South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.3.2 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.4.2 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.5.2 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.6.2 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.7.2 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.9.2 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Lonza
    • 7.1.1 Lonza Company Information
    • 7.1.2 Lonza Introduction and Business Overview
    • 7.1.3 Lonza Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Lonza Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.1.5 Lonza Recent Development
  • 7.2 Biomerieux
    • 7.2.1 Biomerieux Company Information
    • 7.2.2 Biomerieux Introduction and Business Overview
    • 7.2.3 Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.2.5 Biomerieux Recent Development
  • 7.3 Associates of Cape Cod (ACC)
    • 7.3.1 Associates of Cape Cod (ACC) Company Information
    • 7.3.2 Associates of Cape Cod (ACC) Introduction and Business Overview
    • 7.3.3 Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.3.5 Associates of Cape Cod (ACC) Recent Development
  • 7.4 FUJIFILM Wako
    • 7.4.1 FUJIFILM Wako Company Information
    • 7.4.2 FUJIFILM Wako Introduction and Business Overview
    • 7.4.3 FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.4.5 FUJIFILM Wako Recent Development
  • 7.5 Xiamen Bioendo Technology
    • 7.5.1 Xiamen Bioendo Technology Company Information
    • 7.5.2 Xiamen Bioendo Technology Introduction and Business Overview
    • 7.5.3 Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.5.5 Xiamen Bioendo Technology Recent Development
  • 7.6 Rhino Bio
    • 7.6.1 Rhino Bio Company Information
    • 7.6.2 Rhino Bio Introduction and Business Overview
    • 7.6.3 Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.6.5 Rhino Bio Recent Development

8 Industry Chain Analysis

  • 8.1 Recombinant Limulus and Recombinant Factor C Reagent Industrial Chain
  • 8.2 Recombinant Limulus and Recombinant Factor C Reagent Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Recombinant Limulus and Recombinant Factor C Reagent Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Recombinant Limulus and Recombinant Factor C Reagent Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Recombinant Limulus and Recombinant Factor C Reagent Market Trends
  • Table 2. Recombinant Limulus and Recombinant Factor C Reagent Market Drivers & Opportunity
  • Table 3. Recombinant Limulus and Recombinant Factor C Reagent Market Challenges
  • Table 4. Recombinant Limulus and Recombinant Factor C Reagent Market Restraints
  • Table 5. Global Recombinant Limulus and Recombinant Factor C Reagent Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Recombinant Limulus and Recombinant Factor C Reagent Revenue Market Share by Company (2020-2025)
  • Table 7. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Recombinant Limulus and Recombinant Factor C Reagent Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Limulus and Recombinant Factor C Reagent
  • Table 13. Global Recombinant Limulus and Recombinant Factor C Reagent Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Limulus and Recombinant Factor C Reagent as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, (2026-2031) & (K Units)
  • Table 57. Lonza Company Information
  • Table 58. Lonza Introduction and Business Overview
  • Table 59. Lonza Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Lonza Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 61. Lonza Recent Development
  • Table 62. Biomerieux Company Information
  • Table 63. Biomerieux Introduction and Business Overview
  • Table 64. Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 66. Biomerieux Recent Development
  • Table 67. Associates of Cape Cod (ACC) Company Information
  • Table 68. Associates of Cape Cod (ACC) Introduction and Business Overview
  • Table 69. Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 71. Associates of Cape Cod (ACC) Recent Development
  • Table 72. FUJIFILM Wako Company Information
  • Table 73. FUJIFILM Wako Introduction and Business Overview
  • Table 74. FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 76. FUJIFILM Wako Recent Development
  • Table 77. Xiamen Bioendo Technology Company Information
  • Table 78. Xiamen Bioendo Technology Introduction and Business Overview
  • Table 79. Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 81. Xiamen Bioendo Technology Recent Development
  • Table 82. Rhino Bio Company Information
  • Table 83. Rhino Bio Introduction and Business Overview
  • Table 84. Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 86. Rhino Bio Recent Development
  • Table 87. Key Raw Materials Lists
  • Table 88. Raw Materials Key Suppliers Lists
  • Table 89. Recombinant Limulus and Recombinant Factor C Reagent Downstream Customers
  • Table 90. Recombinant Limulus and Recombinant Factor C Reagent Distributors List
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Recombinant Limulus and Recombinant Factor C Reagent Product Picture
  • Figure 2. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Recombinant Limulus and Recombinant Factor C Reagent Report Years Considered
  • Figure 7. Global Recombinant Limulus and Recombinant Factor C Reagent Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Recombinant Limulus and Recombinant Factor C Reagent Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Limulus and Recombinant Factor C Reagent Revenue in 2024
  • Figure 10. Recombinant Limulus and Recombinant Factor C Reagent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Recombinant Limulus Reagent Picture
  • Figure 12. Recombinant Factor C Picture
  • Figure 13. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Pharmaceutical
  • Figure 19. Product Picture of Medical Devices
  • Figure 20. Product Picture of Others
  • Figure 21. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume (%), (2020-2031)
  • Figure 38. United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Recombinant Limulus and Recombinant Factor C Reagent Industrial Chain
  • Figure 60. Recombinant Limulus and Recombinant Factor C Reagent Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed